FDA approves novel flu medication produced from UT research
November 20, 2018
A new prescription flu drug, Xofluza, created with research done 40 years ago by Robert Krug, professor emeritus of molecular biosciences, was recently approved by the Food and Drug Administration and will be available across the U.S. in the coming weeks.